Drugs / CD8-positive WT1 gene-specific CTL clones

Trials 1 · a red edge is where a trial was stopped

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00052520 Sep 2002 → Apr 2011 B-cell adult acute lymphocytic leukemia, B-cell childhood acute lymphoblastic leukemia, T-cell adult acute lymphocytic leukemia, T-cell childhood acute lymphocytic leukemia +11 Fred Hutchinson Cancer Center Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CD8-positive WT1 gene-specific CTL clones “Donors undergo leukapheresis for stem cell harvest to generate CD8-positive WT1 gene-specific CTL clones at the time of allogeneic stem cell transplantation.” NCT00052520
Action Deplete “Immunotherapy given to patients who have undergone donor stem cell transplantation may be a way to eradicate remaining cancer cells” NCT00052520
Modality Cell therapy “adoptive immunotherapy with CD8+ WT1-Specific CTL Clones” NCT00052520
Route Intravenous “CD8-positive WT1 gene-specific CTL clones intravenously (IV)” NCT00052520
Target WT1 “CD8-positive WT1 gene-specific CTL clones” NCT00052520